SETDB1 and hepatocellular carcinoma: miRNA-29 contributes to the modulation of several genes, such as the upregulation of SET domain bifurcated 1 (SETDB1), an H3K9-specific histone methyltransferase, which is significantly associated with HCC disease progression, cancer aggressiveness, and poorer prognosis [79].